BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28215245)

  • 1. Effects of renal sympathetic denervation on blood pressure, sleep apnoea severity and metabolic indices: a prospective cohort study.
    Daniels F; De Freitas S; Smyth A; Garvey J; Judge C; Gilmartin JJ; Sharif F
    Sleep Med; 2017 Feb; 30():180-184. PubMed ID: 28215245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
    Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A
    Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of efficacy between continuous positive airway pressure and renal artery sympathetic denervation by radiofrequency ablation in obstructive sleep apnea syndrome patients with hypertension].
    Zhao MM; Tan XX; Ding N; Zhang XL
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1234-7. PubMed ID: 23902614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial.
    Warchol-Celinska E; Prejbisz A; Kadziela J; Florczak E; Januszewicz M; Michalowska I; Dobrowolski P; Kabat M; Sliwinski P; Klisiewicz A; Topor-Madry R; Narkiewicz K; Somers VK; Sobotka PA; Witkowski A; Januszewicz A
    Hypertension; 2018 Aug; 72(2):381-390. PubMed ID: 29941516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive sleep apnoea, resistant hypertension and renal denervation.
    Witkowski A; Kadziela J
    EuroIntervention; 2013 May; 9 Suppl R():R105-9. PubMed ID: 23732140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
    Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
    Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
    Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension.
    Lloberes P; Lozano L; Sampol G; Romero O; Jurado MJ; Ríos J; Untoria MD; Tovar JL
    J Sleep Res; 2010 Dec; 19(4):597-602. PubMed ID: 20545837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry.
    Linz D; Mancia G; Mahfoud F; Narkiewicz K; Ruilope L; Schlaich M; Kindermann I; Schmieder RE; Ewen S; Williams B; Böhm M;
    J Hypertens; 2017 Jan; 35(1):148-153. PubMed ID: 27906840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-based renal sympathetic denervation for the treatment of resistant hypertension: first experience in Greece with significant ambulatory blood pressure reduction.
    Tsioufis C; Dimitriadis K; Tsiachris D; Thomopoulos C; Kasiakogias A; Kordalis A; Kefala A; Kallikazaros I; Stefanadis C
    Hellenic J Cardiol; 2012; 53(3):237-41. PubMed ID: 22653249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S; Ormiston J; Bergmann MW; Sievert H; Schwindt A; Werner N; Vogel B; Colombo A
    EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial.
    Kario K; Bhatt DL; Kandzari DE; Brar S; Flack JM; Gilbert C; Oparil S; Robbins M; Townsend RR; Bakris G
    Circ J; 2016 May; 80(6):1404-12. PubMed ID: 27118620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular ultrasound for renal sympathetic denervation in patients with therapy-resistant hypertension not responding to radiofrequency renal sympathetic denervation.
    Stiermaier T; Okon T; Fengler K; Mueller U; Hoellriegel R; Schuler G; Desch S; Lurz P
    EuroIntervention; 2016 Jun; 12(2):e282-9. PubMed ID: 27290688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
    Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.
    Durán-Cantolla J; Aizpuru F; Montserrat JM; Ballester E; Terán-Santos J; Aguirregomoscorta JI; Gonzalez M; Lloberes P; Masa JF; De La Peña M; Carrizo S; Mayos M; Barbé F;
    BMJ; 2010 Nov; 341():c5991. PubMed ID: 21106625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of CPAP to reduce arterial stiffness in moderate-to-severe obstructive sleep apnoea, without excessive daytime sleepiness (STIFFSLEEP): an observational cohort study protocol.
    Mineiro MA; Marques da Silva P; Alves M; Virella D; Marques Gomes MJ; Cardoso J
    BMJ Open; 2016 Jul; 6(7):e011385. PubMed ID: 27406645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of obstructive sleep apnoea after renal denervation is not associated with hypertension exaggeration.
    Korostovtseva LS; Ionov MV; Shcherbakova EA; Bochkarev MV; Emelyanov IV; Yudina YS; Mironova SA; Zverev DA; Lebedev DS; Vakhrushev AD; Avdonina NG; Zvartau NE; Mikhaylov EN; Sviryaev YV; Konradi AO
    BMC Pulm Med; 2023 Nov; 23(1):467. PubMed ID: 37996833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.